Copernicare

Name: Copernicare
Brand: Copernicare

One integrated platform for all Track & Trace, stock management and optimization of the flow of goods in healthcare.

Est 2010|14 Ref Customers

LinkedIn 578|Website|FTEs 4|HQ Hoofddorp, North Holland, NL

MarketsSupply Chain Visibility Materials Management

Published Oct 15, 2026

01Common complaints

- Company sizes or stages where this product is overkill or insufficient - Overkill - Small outpatient centers without complex OR/CSA logistics and without strict implant traceability needs. - Potentially insufficient - Very large multinational hospital networks needing global support, extensive multi-country compliance features, and broad third-party ecosystem integrations beyond NL/EU focus. - Industries or use cases where competitors are more appropriate - If your primary need is supplier-network procurement and end-to-end supply chain network coordination, a supply chain network vendor (e.g., GHX) may be more appropriate. - Technical requirements that this product may not meet (require validation) - Not enough public technical documentation to confirm constraints; buyers should validate: - API availability - Data model extensibility - High availability/DR posture - Hosting and data residency options - Budget constraints that make alternatives more appropriate - If you need transparent self-serve pricing and minimal implementation effort, CoperniCare’s enterprise/quote-based model and integration-heavy nature may be a poor fit. - Specific workflows or integrations where the product may fall short - Not proven publicly; but hospitals with highly customized EHR workflows may encounter interface constraints. - Red flags in the buying process - Lack of public pricing and limited independent reviews increases diligence burden. - Request written commitments on: - Integration deliverables and timelines - Support response SLAs - Upgrade policy (especially if custom modules are built) - Current limitations acknowledged by the vendor - Not clearly stated in accessible sources. - Features on the roadmap (not yet available) - Not found in accessible sources. - Scale limitations (at what volume/size does it break down?) - Not publicly documented. - Security or compliance gaps - Beyond ISO 27001, security attestations and detailed controls are not publicly documented. - Technical debt or architectural limitations mentioned in reviews - Not found. - API limitations or integration constraints - Not publicly documented; integration claims are broad and should be validated via reference architectures and proofs of concept.

Deal disqualifiers: what indicates a poor fit

Very small clinics with low procedure volume where process overhead outweighs benefit
Organizations that cannot commit to disciplined scanning/registration behaviors
Environments with constrained IT integration capacity or rigid EHR/ERP vendor constraints

Why some customers left for competitors (churn reasons)

Not found in accessible sources.

02Why they buy

- Customer-validated advantages (evidence-limited) - Independent feedback is limited. Vendor case quotes indicate improvements in staff experience and operational metrics, but these are vendor-published and require independent validation. - Features and capabilities that may differentiate the product - Integrated coverage across multiple track & trace domains (instruments, implants, tissue, equipment) aligned to Dutch hospital workflows and registry requirements. - MediTracker component for instrument-level tracking across CSA processes. - Integration focus with EPD/ERP systems to enable patient-level consumption registration. - Differentiation from competitors based on available evidence - The product emphasizes hospital-internal traceability workflows more than broad supplier-network features. - Value propositions with evidence from case studies - VVS PDF claim of inventory reductions (vendor-provided) should be validated through customer references and measurement methodology. - Areas where competitors have documented advantages - Larger enterprise vendors often provide: - Published Trust Centers and compliance artifact access - More third-party reviews and analyst coverage - Broader partner ecosystems

Why customers chose this product over alternatives (inferred from vendor materials)

Integration with existing EPD/ERP to reduce duplicate entry and enable patient-level registration
End-to-end logistics visibility (OR/OK, CSA, central logistics)
Traceability to support regulatory requirements for implants and other regulated items

03Field reports

Availability caveat (important)

CoperniCare does not appear to have broad coverage on major SaaS review platforms under an easily discoverable product listing.
As a result, available review evidence is heavily skewed toward vendor-published case studies and a small set of third-party aggregator pages of uncertain quality.

Direct quotes from Gartner Peer Insights, Reddit, TrustRadius, G2, HackerNews

- Gartner Peer Insights - Attempted but inaccessible/not found: no CoperniCare product page or reviews located via accessible search results; only general portal pages were reachable. - G2 - Attempted but not found: no CoperniCare product listing/review page discovered in accessible results. - TrustRadius - Attempted but not found: no CoperniCare listing/reviews discovered. - Reddit - Attempted but not found: no substantive Reddit discussions specifically about CoperniCare discovered in accessible results. - HackerNews - Attempted but not found: no discussions found on accessible news discussion forums for CoperniCare. - Third-party aggregator (not in the requested list, but one of the only sources that surfaced reviews) - One third-party aggregator hosts a CoperniCare review page with an average rating and a small number of short reviews; authenticity is difficult to validate. Example paraphrase from a review: - A reviewer described CoperniCare as a reputable vendor that provides healthcare logistics solutions (third-party aggregator user review).

Vendor-published case-study quotes (not independent reviews)

OLVG case snippet on the CoperniCare site includes a vendor-attributed comment that staff experienced improved calm and operational stability after the deployment.
Bernhoven case snippet includes a vendor-attributed comment referencing increased patient safety, cost savings, and efficiency.

BALANCE assessment

Because independent review platforms and community discussions were not discoverable, there is insufficient credible negative user feedback available to balance against the vendor-published case studies.
This is a material gap for buyers who rely on peer reviews.

Specific outcomes customers achieved (with metrics when available)

Vendor materials claim notable inventory reductions are possible with good registration and stock-process control.
- This appears as a vendor-provided claim without disclosed methodology or baseline; treat as vendor-reported and validate with onsite metrics.
Case pages mention reduced expiry waste, lower inventories, and efficiency gains (mostly qualitative in the accessible snippets).

Customer pain points and frustrations mentioned in reviews

Not available from credible independent sources in the accessible dataset.

Deal-breakers and reasons customers didn't purchase

Not available from credible independent sources.

OLVG (vendor case page)

Reported benefits (vendor summary): lower inventories, reduced waste due to expiration, improved efficiency, and better staff experience.
Critical evaluation
- Metrics are not fully visible in accessible snippets; the methodology and baseline are not provided publicly.

Bernhoven (vendor case page)

Reported benefits: improved patient safety, cost savings, more efficient work; full registration of medical devices and implants.
Critical evaluation
- Statements are attributed to an operational leader (qualitative evidence), but remain vendor-published without independent verification.

St. Antonius Ziekenhuis (vendor page snippet on homepage)

Reported rollout: MediTracker deployment in OR/OK contexts to improve instrument processes and information exchange between CSA and OK.
Critical evaluation
- No quantified outcome metrics were found in the accessible snippet.

CSA Services B.V. (vendor news)

Reported benefits: CSA Services selected MediTracker for instrument management; they report registering net/instrument data and applying automated track & trace across the process.
Critical evaluation
- Indicates adoption by a sterilization services provider; content is vendor-published.

VVS (PDF)

Reported claim: vendor-sourced claim of a notable inventory reduction.
Critical evaluation
- This is a vendor-sourced claim without a disclosed study design (sample size, departments, timeframe, definition of "inventory," and controls). Treat as potential upside and validate with third-party or onsite data.

04Best fit

Company sizes

Likely appropriate fit:
- Mid-to-large hospitals and multi-site hospital groups that have OR/OK + CSA operations and a meaningful implant/instrument volume.
- Institutions large enough to justify integration projects; specific employee and revenue ranges are not documented publicly.

Industries and verticals where adoption is strongest (with customer examples)

Acute care hospitals (examples shown on vendor site): OLVG, Bernhoven, UMC Utrecht, AMC, HagaZiekenhuis, St. Antonius Ziekenhuis.

Roles and personas: decision makers AND end users

Decision makers
- Hospital operations leadership (OR/OK, logistics)
- IT integration leadership (EPD/ERP integration)
- Procurement / supply chain management
- Compliance / quality (implant registry obligations)
End users
- OR/OK logistics staff
- CSA technicians/managers
- Inventory managers
- Nurses/OR staff who perform scanning and registration tasks

Pain points and challenges the product addresses

Traceability gaps for instruments/implants and recall readiness
Inventory waste (expiration) and stock-outs
Manual/duplicate registration across systems

Qualification criteria: what indicates a good fit

Executive sponsorship for standardizing scanning/registration workflows
Willingness to invest in integration and data governance
Clear compliance traceability requirements (implants, tissue, etc.)

Real customer examples with company names when available

OLVG
Bernhoven
Spaarne Gasthuis
St. Antonius Ziekenhuis
CSA Services B.V.

05The pitch

What the product does (core value proposition in objective terms)

- CoperniCare is a healthcare logistics software platform focused on: - Track & Trace of medical items (e.g., implants, instruments, consumables, tissue, equipment) across hospital workflows - Inventory/stock management (receiving, consumption registration, replenishment) - Integrations ("koppelingen") with hospital source systems (EPD/EHR, ERP, national registries, etc.) to reduce duplicate data entry and improve traceability and regulatory compliance - The vendor describes the platform as a single integrated solution for hospital logistics and traceability.

Target market and market positioning

Primary target market appears to be Dutch hospitals, clinics, and sterile services / CSA (Central Sterilization Department) organizations.
Positioning (vendor description paraphrased):
- Support for hospital workflow automation through logistics-focused processes and standardized registration across departments
- Traceability designed to meet regulated-item requirements such as those for implants

Get a comprehensive analysis of Copernicare including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →